Application of new modern biopharmaceutical technology in the current medical field
Application of new modern biopharmaceutical technology in the current medical field
From the perspective of the world at present, more than 50% of new biotechnology research has been applied to the field of medical research, in which the pharmaceutical engineering field accounts for the vast majority of the proportion, which to a large extent has brought very important changes to the current pharmaceutical industry production system. In view of the above situation, the author believes that it is necessary to conduct reasonable research and analysis on the actual application of new modern biopharmaceutical engineering technology in the current medical field.
2.1 Research on the application of gene splicing technology in the current medical field
The substances necessary for normal physiological metabolism and regulation of various skills are active factors and hormones, which have the advantage of relatively strong activity, and have a good effect when applied to the diagnosis and treatment process. Therefore, many researchers attach importance to them. However, there are some problems in the actual application process, because these substances do not exist in large quantities in nature, and it can be said that it is quite difficult to obtain them by using methods extracted from animals or human bodies, and because of technical problems, there are many difficulties, their sources are relatively limited, but the clinical treatment needs are unlimited, This leads to the contradiction between supply and demand, and the new and modern biopharmaceutical engineering technologies currently used provide a very effective solution to the problems in this area. This article takes insulin as an example. This kind of medicine has excellent effects in the diagnosis and treatment of diabetes. In the past, insulin was usually extracted from animals. On the one hand, resources are relatively scarce, and the cost of investment is relatively high. Using the current new genetic engineering to extract insulin not only reduces the harm to humans and animals in the process of insulin extraction, Moreover, it can also use the technology related to gene recombination to achieve the effect of mass production and production of insulin drugs. According to relevant statistical data, in the actual process of insulin extraction, 10 grams of insulin can be extracted in a 200 liter fermentation tank by using new genetic engineering bacteria, which is equivalent to 450 kg of insulin extracted in the pancreas. Normally, insulin extracted from human body is usually produced due to the secretion of the pituitary gland, which leads to less production under normal conditions, and it is still difficult to extract, and the application process will be subject to certain restrictions. In this case, the industry will further enhance the importance of genetic engineering in the future research process. From the current actual situation, the new way of extracting insulin based on new genetic engineering technology has gradually become a very popular method in the medical field of our country, and this hormone has been widely used in clinical treatment work at present, and to a large extent, it meets the actual needs of clinical medical work.